Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boceprevir in Asia Pacific Subjects with Chronic Hepatitis C Genotype 1
NCT01390844Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2011
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of boceprevir in hepatitis C (HCV), sponsored by Merck & Co.. Started Oct 2011; status: completed.
02
Drugs
boceprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01390844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01390844.